Data on genotype–phenotype correlations in MPS II are limited, although patients with large deletions or rearrangements in the IDS gene resulting in complete loss of functional enzyme have the neuronopathic form of MPS II as well as severe somatic manifestations, including cardiac involvement.6, 7, 8, 9. The gene discussed is IDS; the disease is mucopolysaccharidosis type 2.